Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms

NCT: NCT07316088 · ACTIVE_NOT_RECRUITING

NCT IDNCT07316088
StatusACTIVE_NOT_RECRUITING
Start Date2025-12-09
Completion2026-08-17
SponsorOui Therapeutics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.

Frequently Asked Questions

What is Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms?

Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms is a clinical trial registered under NCT07316088. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07316088?

The current status of NCT07316088 (Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms) is: ACTIVE_NOT_RECRUITING.

When did Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms start?

Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms started on 2025-12-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑